|
⚲
|
| Keyboard |
| Perry Karsen | |
|---|---|
| Firm | |
| Address | c/o Graphite Bio, Inc 279 East Grand Avenue, Suite 430 South San Francisco, CA 94080 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Graphite Bio Inc | 021-392907 | Director | 150.7 M of 150.7 M |
||
| Jounce Therapeutics Inc | 021-379231 | Director | 35.0 M of 35.0 M |
||
| Escape Bio Inc | 021-376482 | Director | 73.0 M of 73.0 M |
||
| E-Scape Bio Inc | 021-345261 | Director | 31.1 M of 35.0 M |
||
| E-Scape Bio Inc | 021-246718 | Director | 63.0 M of 63.0 M |
||
| Alliqua Inc | 021-217404 | Director | 2.0 M of 7.0 M |
||
| Alliqua Inc | 021-216411 | Director | 15.0 M of 15.0 M |
||
| Agios Pharmaceuticals Inc | 021-169115 | Director | 78.0 M of 78.0 M |
||